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Background
Aim of this study was to evaluate the clinical and hemo-
dynamic results at 5 years of Medtronic 3F® stentless
equine pericardial aortic valve.
Methods
Between March 2007 and December 2012 a total of 120
consecutive patients affected by aortic valve disease
received a 3F valve at our unit. The size ranged between
21 and 29, with prevalence of 23 and 25 implants .Mean
age at operation was 75,6 ± 8,0 years, 54% were males,
the mean logistic EuroScore was 8,7 ± 5,2 and 47%
received concomitant procedures. For isolated replace-
ments the mean ECC time was 90’ ± 10’, Cross Clamp
time 72’ ± 8’.In 12 pts the aortic prosthesis was included
in a Dacron tube straight graft for a Bentall operation.
Results
Early mortality in isolated AVR was 2,1% and 3,1% in
the entire group. There have been 6 late all-causes
deaths (5,6%) ,with a survival of 90% at 5 yrs. 91% of
patients are in NYHA class I or II. Actuarial freedom
from reoperation for structural deterioration is 100% at
5 years. Freedom from endocarditis and thromboem-
bolic events was 96% and 99% respectively. The 72
patients evaluated under exercise at 75w protocol
showed a moderate increase in the MPG (from 7,8 ±
3,3mmHg to 11,6 ± 4.0mmHg) for the entire series at
five years follow up.
Conclusions
The 3F valve shows excellent hemodynamics, durability
and freedom from structural deterioration at 5 yrs fol-
low-up. Freedom from endocarditis and thromboem-
bolic events looks satisfactory. Longer follow-up times
are needed for a better evaluation of this interesting
new generation of user friendly aortic valve substitute.
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